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 Abstract 
 Background: Celiac disease (CD) is an autoimmune entero-
pathy characterized by villus atrophy and malabsorption of 
essential nutrients. Vitamin D defi ciency has been described 
in autoimmune diseases, but its status in prepubertal children 
with CD has not been adequately studied. 
 Objective: To determine the vitamin D status of prepubertal 
children with CD. 
 Study design: A retrospective study of prepubertal children 
aged 3 – 12 years with CD (n = 24) who were compared to pre-
pubertal, non-CD children of the same age (n = 50). Children 
were included in the study if they had a diagnosis of CD by 
intestinal biopsy, and were not on a gluten-free diet (GFD). 
Patients were excluded if they had diseases of calcium or vita-
min D metabolism, or were receiving calcium or vitamin D 
supplementation or had other autoimmune diseases. All sub-
jects had their serum 25-hydroxyvitamin D [25(OH)D] level 
measured. 
 Results: There was no difference in 25(OH)D level between 
the CD and non-CD children (27.58 ± 9.91 vs. 26.20 ± 10.45, 
p = 0.59). However, when the patients were subdivided into 
obese and non-obese groups, the non-obese CD patients had 
a signifi cantly higher 25(OH)D level than the obese normal 
children (28.39 ± 10.26 vs. 21.58 ± 5.67, p = 0.009). In contrast, 
there was no difference in 25(OH)D level between non-obese 
CD patients and non-obese normal children (28.39 ± 10.26 vs. 
30.64 ± 12.08, p = 0.52). The season of 25(OH)D measurement 
was not a signifi cant confounder (p = 0.7). 
 Conclusions: Our data showed no difference in 25(OH)
D levels between normal children and those with CD when 
adjusted for body mass index. 
 Keywords:  celiac disease;  children;  prepubertal status;  vita-
min D. 
 Introduction 
 Celiac disease (CD) is an autoimmune enteropathy that affects 
0.5 – 1 % of the population  (1) . It is characterized by villus atro-
phy and malabsorption of essential nutrients. The pathogenesis 
of CD is based on a combination of genetic and environmental 
factors  (2) . The most important predisposing genetic factors to 
CD are HLA-DQ2 and HLA-DQ8 mole cules  (3) . There is a 70 % 
concordance for CD in monozygotic twins  (2) . Environmental 
factors, such as the time of initial exposure of intestinal epithe-
lium to gluten  (4) , as well as the duration of gluten exposure are 
also associated with the development of CD  (5) . 
 Gluten is a protein component in wheat, rye and barley. 
The toxicity associated with these proteins is related to glu-
tamine and proline-rich amino acid sequences  (2) . An immune 
response, mostly within the lamina propria, leads to the release 
of tissue transglutaminase from infl amed cells  (2) . Tissue trans-
glutaminase is an intracellular enzyme that can interact with 
glutamine and proline-rich proteins, such as those in gluten  (2) . 
These interactions can generate new antigens that are targeted 
by immunoglobulin A fraction in patients who are genetically 
predisposed to develop CD. Tissue transglutaminase enzyme, 
an autoantigen in CD  (6) deamidates gluten peptides leading 
to increased immunoreactivity of the gluten peptides  (7) . The 
small bowel damage from activated CD 8 + cells is charac-
terized histologically by an invasion of lymphocytes into the 
epithelium and lamina propria, progression to crypt hyperpla-
sia, and fi nally to blunting of intestinal villi  (2) . Resolution 
of these intestinal lesions can occur after the removal of the 
inciting proteins from the susceptible individual ’ s diet  (8, 9) . 
Untreated CD, however, is associated with malnutrition in 
67 % of patients  (10) . Interestingly, obesity has been reported 
in children with CD at a prevalence rate of 5 %  (11) . 
 The role of intestinal epithelial damage on vitamin D 
absorption in prepubertal children with CD has not been fully 
studied. Vitamin D receptors are present in the crypts of CD 
intestine, and it is unclear whether the intestinal infl amma-
tion of CD leads to malabsorption of fat-soluble vitamins, and 
consequent vitamin D defi ciency  (12) . Vitamin D defi ciency 
has been reported in related autoimmune diseases, such as 
type 1 diabetes mellitus and chronic lymphocytic thyroiditis 
 (13, 14) , which are frequently seen in patients with CD  (14) . 
Some investigators have speculated that the intestinal dam-
age in CD could result in vitamin D malabsorption and vita-
min D defi ciency  (9, 10) . Lerner et al  (3) studied two cohorts 
of patients with CD living in two sunny countries, Israel and 
Spain, and found that serum concentrations of vitamin D is 
negatively correlated with age, but not with the degrees of 
intestinal damage. However, the vitamin D metabolism in 
prepubertal children with CD in cold climates has not been 
fully studied. This is important because even though children 
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in both cold and sunny climates may have a similar degree of 
villus atrophy, the increased exposure to ultraviolet radiation 
in sunny countries could easily lead to normal vitamin D lev-
els in children in contrast to children living in colder climates 
with limited exposure to ultraviolet radiation. 
 Therefore, to bridge this knowledge gap, we designed this 
study with the primary aim of determining whether vitamin 
D insuffi ciency is a feature of CD in prepubertal children 
living in cold climates along 42 ° N. Our hypothesis was that 
CD children would have low vitamin D levels compared to 
healthy children. To examine this hypothesis we conducted 
a retrospective chart review of children with CD who had 
25(OH)D measured, and compared this group to a cohort 
of healthy prepubertal children who participated in a pro-
spective cross-sectional study on the role of vitamin D 
metabolism on bone mineral content (clinical trial identifi er 
NCT00756899). 
 Study participants 
 We reviewed the medical records of prepubertal children 
aged 3 – 12 years with CD at the Children ’ s Medical Center 
of the Umass Memorial Medical Center between 2008 and 
2011. The study protocol was approved by the University of 
Massachusetts Institutional Review Board. Study subjects 
(n = 24; 15 females and nine males) were included if they had 
a diagnosis of CD, had 25(OH)D level measured at diagnosis, 
were not on gluten-free diet (GFD), and were not taking vita-
min D or calcium supplementation. Patients were excluded 
if they had diseases of calcium or vitamin D metabolism or 
had other autoimmune diseases. Diagnosis of CD was based 
upon upper gastrointestinal biopsies consistent with CD clini-
cal presentation. Age was determined by the date of 25(OH)D 
measurement. Subjects were categorized into non-obese and 
obese categories, using a body mass index (BMI) of  > 95th 
percentile to defi ne obesity  (15) . 
 A group of 50 age-matched healthy prepubertal children 
who participated in a cross-sectional study entitled  ‘ The 
Relationship between Vitamin D Defi ciency and Low Bone 
Mineral Content in Children ’ , ClinicalTrials.gov Identifi er: 
NCT00756899, at the Children ’ s Medical Center of the Umass 
Memorial Medical Center, served as normal controls. All sub-
jects in the control group were prepubertal, had no diagnosis 
of CD, and were not on vitamin D or calcium supplementa-
tion. They had no medical diseases affecting calcium or vita-
min D metabolism. Their age was determined by the date of 
25(OH)D measurement. This group consisted of 25 obese and 
25 non-obese subjects. 
 Anthropometry 
 Height was measured to the nearest 0.1 cm using a wall-
mounted stadiometer (Holtain Ltd, Crymych, Dyfed, UK). 
Weight was measured to the nearest 0.1 kg using an upright 
scale. BMI was derived using the formula weight/height 2 
(kg/m 2 ), and expressed as standard deviation score (SDS) for 
age and gender based on National Center for Health Statistics 
(NCHS) data  (16) . 
 Assays 
 The 25(OH)D was assayed by chemiluminescence immuno-
assay which has 100 % cross-reactivity with both vitamin D 2 
(the plant-derived form of vitamin D called ergocalciferol) and 
D 3 (the animal derived form known as cholecalciferol). The 
immunoassay detects total body 25(OH)D content. Its func-
tional sensitivity is 4 ng/mL (10 nmol/L), and its  intra - and 
 inter -assay coeffi cients of variation are 5 % and 8.2 % , respec-
tively. Vitamin D defi ciency was defi ned as a 25(OH)D level 
of  < 15 ng/mL, (37.5 nmol/L), vitamin D insuffi ciency as vita-
min D level of 15 – 20 ng/mL, (37.5 – 50 nmol/L), and vitamin D 
suffi ciency as 25(OH)D of  > 20,100 ng/mL, (50 – 250 nmol/L) 
based on Pediatric Endocrine Society guidelines  (17) . 
 Statistics 
 Statistical analyses were performed using the SPSS Predictive 
Analytics SoftWare version19 (IBM Corporation, Somers, 
NY, USA). Means and standard deviations were calculated for 
descriptive summary statistics. Anthropometrics and 25(OH)
D levels were compared using Student ’ s t-test. Seasons were 
compared using Fisher ’ s exact test. BMI was expressed as a 
standard deviation score (SDS). 
 Results 
 The baseline characteristics of the study patients and con-
trols are shown in Table  1 . There was no difference in 
mean 25(OH)D level between the CD and non-CD children 
(27.58 ± 9.91 vs. 26.20 ± 10.45, p = 0.59). However, when the 
patients were subdivided into obese and non-obese groups, 
the non-obese CD patients had a signifi cantly higher mean 
25(OH)D level than the obese normal children (28.39 ± 10.26 
vs. 21.58 ± 5.67, p = 0.009) (Figure 1). In contrast, there was 
no difference in mean 25(OH)D level between non-obese 
CD patients and non-obese normal children (28.39 ± 10.26 
vs. 30.64 ± 12.08, p = 0.52). Similarly, there was no differ-
ence in BMI SDS between non-obese CD patients and non-
obese normal children ( – 0.03 ± 1.28 vs. 0.03 ± 1.12, p = 0.87). 
Mean BMI SDS differed signifi cantly between obese nor-
mal children and non-obese normal children (2.54 ± 0.87 vs. 
0.03 ± 1.12 p < 0.001); and also between obese normal chil-
dren and non-obese CD patients (2.54 ± 0.87 vs.  – 0.03 ± 1.28 
p < 0.001). The seasonality of 25(OH)D measurement was not 
a signifi cant confounder (p = 0.70). 
 Discussion 
 We found no difference in mean 25(OH)D levels between 
normal children and those with CD when adjusted for BMI. 
We also found that obese children in general had lower vita-
min D levels compared to non-obese children. 
 Our fi nding is similar to other reports on vitamin D metab-
olism in CD  (3, 9) . Lerner et al  (3) conducted a transcon-
tinental study involving groups of children and adults with 
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CD to determine the effect of CD on vitamin D metabolism. 
They found no evidence of vitamin D defi ciency in their pedi-
atric patients. In contrast, they found signifi cant vitamin D 
defi ciency in their adult population. They explained that this 
discrepancy could be caused by the fact that children with 
CD have increased dietary intake of vitamin D, are routinely 
supplemented with vitamin D in the fi rst year of life, have 
more exposure to sunlight, and are more compliant with a 
gluten-free diet compared to adult CD patients. Thus, despite 
the malabsorptive state in CD, vitamin D defi ciency is not a 
feature of pediatric CD as vitamin D status may be unrelated 
to the degree of small bowel injury in CD  (9) . A possible rea-
son for the lack of vitamin D defi ciency in children with CD 
is that a majority of the hormone is produced in the skin upon 
exposure to ultraviolet radiation  (18) . Therefore, body stores 
might depend more on endogenous production rather than 
gastrointestinal absorption. 
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Figure 1 Box plots of the comparison of serum concentrations of 
25-hydroxyvitamin D in patients with celiac disease and normal con-
trols stratifi ed by body mass index.
 Table 1  Comparison of the characteristics of children with celiac disease and those of normal children. 
Parameters Celiac disease patients Normal controls
Number All 24 Obese 6 Non-obese 18 All 50 Obese 25 Non-obese 25
Age, year 9.42 ± 2.80 10.31 ± 2.61  9.12 ± 2.87  8.02 ± 2.66  8.48 ± 2.55  7.56 ± 2.73
Sex, males 9 2 7 29 16 13
Height SDS  – 0.64 ± 1.32  – 0.87 ± 1.97  – 0.56 ± 1.10  0.21 ± 1.71  0.96 ± 1.51  – 0.55 ± 1.57
Weight SDS  0.06 ± 1.45  1.43 ± 0.63  – 0.39 ± 1.36  1.08 ± 1.96  2.55 ± 1.04  – 0.03 ± 1.12
BMI SDS  0.47 ± 1.42  1.97 ± 0.27  – 0.03 ± 1.28  1.29 ± 1.61  2.54 ± 0.87  0.03 ± 1.12
25(OH)D, ng/mL 27.58 ± 9.91 25.17 ± 9.17 28.39 ± 10.26 26.20 ± 10.45 21.58 ± 5.67 30.64 ± 12.08
Seasons (summer + autumn) 11 4 7 17 8 9
 25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; SDS, standard deviation score. 
 Our fi nding that obese children had lower vitamin D lev-
els compared to non-obese children is consistent with previ-
ous reports on the relationship between 25(OH)D and BMI 
 (19 – 22) .The proposed reasons for vitamin D defi ciency 
in the obese state include sequestration of vitamin D in 
excess body fat, negative feedback from an elevated 1-25-
dihydroxyvitamin D level, poor diet, or an avoidance of sun-
light  (20 – 22) . 
 One of the limitations of our study is its cross-sectional 
design, which makes it diffi cult to establish temporality in 
25(OH)D levels. Secondly, our results cannot be generalized 
because our patients were all residing in central Massachusetts, 
located at 42 ° N, a geographical zone that receives insuffi -
cient amounts of ultraviolet radiation in the winter months 
for adequate skin synthesis of vitamin D. However, the blood 
samples for the study parameters were collected at different 
seasons of the year. We also had a smaller sample size for 
the CD patients compared to non-CD cohort. For example, 
we had only six obese patients with CD. Such a sample size 
would be inadequate to detect subtle differences between the 
groups and could have resulted in type 2 error. However, the 
proportion of obese patients with CD in our cohort is consis-
tent with the 5 % prevalence rate of obesity in the pediatric CD 
population  (11) . In contrast, we had a representative number 
of patients in the non-obese groups for the CD and non-CD 
cohorts to accurately assess the effects of CD on vitamin D 
metabolism in this subset of patients. This group of patients 
was of primary interest for this study because we specifi -
cally wanted to exclude the infl uence of obesity on vitamin 
D metabolism. The strengths of this study include the fact 
that we studied only prepubertal children, thus eliminating 
the effects of hormonal fl uctuations associated with puber-
tal maturation on vitamin D metabolism. We also employed 
a representative group of control subjects in both the obese 
and non-obese cohorts. Finally, we provided a much-needed 
balance to Lerner ’ s study  (3) by investigating the vitamin D 
profi les of children with CD residing in cold climates. 
 In conclusion, our data show that vitamin D defi ciency is 
not a feature of CD in prepubertal children living in cold cli-
mates. This is consistent with an earlier study in sunny cli-
mates which showed normal vitamin D levels in children with 
CD. Therefore, children with CD do not require aggressive 
vitamin D supplementation. 
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